advantageaustria.org does not support this browser, some features and elements are not supported. Please use another browser such as Firefox, Chrome, Edge etc.
TAmiRNA is an R&D company which develops and subsequently licenses the use of microRNAs as biomarkers assisting personalized diagnosis and treatment of age-associated disorders. The lead diagnostic project of TAmiRNA focusses on fracture-risk prediction for Osteoporosis (the most prevalent bone disease): based on the ...
